2020 / 05

Next Paper
DOI: 10.24075/brsmu.2020.062
Copyright: © 2020 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

CLINICAL CASE

Difficulties in differential diagnosis of cutaneous manifestations in patients with coronavirus infection

Tairova RT1,2, Gaydina TA1,2, Dvornikov AS2, Tazartukova AD1, Lyang OV1
About authors

1 Federal Center for Brain and Neurotechnology of FMBA of Russia, Moscow, Russia

2 Pirogov Russian National Research Medical University, Moscow, Russia

Correspondence should be addressed: Tatiana A. Gaydina
Ostrovityanova, 1, Moscow, 117997; ur.xednay@924cod

About paper

Compliance with ethical standards: the patient gave informed consent to medical treatment and publication of this case report.

Author contribution: Tairova RT, Gaydina TA: interpretation of the obtained data, manuscript draft; Dvornikov AS: literature analysis; Tazartukova AD: interpretation of the obtained data; Lyang OV: manuscript draft.

Received: 2020-09-23 Accepted: 2020-10-08 Published online: 2020-10-21
|
  1. Casas C, Catala A, Hernandez G, Rodríguez-Jimenez P, Nieto D, Rodriguez-Villa A, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. British Journal of Dermatology. 2020; 183 (1): 71–77. DOI: 10.1111/bjd.19163.
  2. Almutairi N, Schwartz RA. COVID-2019 with dermatologic manifestations and implications: an unfolding conundrum. Dermatol Therapy. 2020; e13544. Available from: https://doi. org/10.1111/dth.13544.
  3. Recalcati S, Barbagallo T, Frasin LA, Prestinari F, Cogliardi A, Provero MC, et al. Acral cutaneous lesions in the time of COVID-19. J Eur Acad Dermatol Venereol. 2020; 34 (8): e346– e347. DOI: 10.1111/jdv.16533.
  4. Criado PR, Abdalla BMZ, Assis IC, Blarcum de Graaff Mello C, Caputo GC, Vieira IC. Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms. Inflamm Res. 2020; 69 (8): 745–56. DOI: 10.1007/s00011-020-01370-w.
  5. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020; 395 (10223): 470–73. DOI: 10.1016/S0140-6736(20)30185-9.
  6. Formica D, Sultana J, Cutroneo P, et al. The economic burden of preventable adverse drug reactions: a systematic review of observational studies. Expert Opin Drug Saf. 2018; 17 (7): 681– 95. DOI: 10.1080/14740338.2018.1491547
  7. Aung A, Tang M, Adler N, et al. Adverse Drug Reactions Reported by Healthcare Professionals: Reaction Characteristics and Time to Reporting. The Journal of Clinical Pharmacology. 2018; 58 (10): 1332–9. DOI: 10.1002/jcph.1148.
  8. Gelincik A, Brockow K, Celik GE, Dona I, Mayorga C, Romano A, et al. Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19. Allergy. 2020; 10.1111/ all.14439. DOI: 10.1111/all.14439.
  9. Marzano AV, Cassano N, Genovese G, Moltrasio C, Vena GA. Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue. British Journal of Dermatology. 2020; 183 (3): 431–42. DOI: 10.1111/bjd.19264.
  10. Su CJ, Lee CH. Viral exanthem in COVID-19, a clinical enigma with biological significance. J Eur Acad Dermatol Venereol. 2020; 34 (6): e251–e252. DOI: 10.1111/jdv.16469.
  11. Henry D, Ackerman M, Sancelme E, Finon A, Esteve E. Urticarial eruption in COVID-19 infection. J Eur Acad Dermatol Venereol. 2020; 34 (6): e244–e245. DOI: 10.1111/jdv.16472.
  12. Tang K, Wang Y, Zhang H, Zheng Q, Fang R, Sun Q. Cutaneous manifestations of the Coronavirus Disease 2019 (COVID-19): A brief review. Dermatol Ther. 2020: e13528. DOI: 10.1111/ dth.13528.
  13. Vremennye metodicheskie rekomendacii ‘Profilaktika, diagnostika i lechenie novoj koronavirusnoj infekcii (COVID-19)’. Versija 8.1 (01.10.2020), utverzhdennye Ministerstvom zdravoohranenija RF. Available from: https://static-0.minzdrav.gov.ru/system/ attachments/attaches/000/052/219/original/%D0%92%D1% 80%D0%B5%D0%BC%D0%B5%D0%BD%D0%BD%D1% 8B%D0%B5_%D0%9C%D0%A0_COVID-19_%28v.8.1%29. pdf?1601561462. Russian.
  14. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020; 34 (5): e212– e213. DOI: 10.1111/jdv.16387.
  15. Jimenez-Cauhe J, Ortega-Quijano D, Prieto-Barrios M, Moreno- Arrones OM, Fernandez-Nieto D. Reply to "COVID-19 can present with a rash and be mistaken for dengue": Petechial rash in a patient with COVID-19 infection. J Am Acad Dermatol. 2020; 83 (2): e141–e142. DOI: 10.1016/j.jaad.2020.04.016.
  16. Diaz-Guimaraens B, Dominguez-Santas M, Suarez-Valle A, Pindado-Ortega C, Selda-Enriquez G, Bea-Ardebol S, et al. Petechial Skin Rash Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection. JAMA Dermatol. 2020; 156 (7): 820–22. DOI: 10.1001/jamadermatol.2020.1741.